Lung toxicity of lomustine in the treatment of progressive gliomas

BACKGROUND: Pulmonary fibrosis is a rare, but dangerous side effect of CCNU (lomustine). CCNU is a frequently used chemotherapeutic agent in the setting of recurrent or progressive glioblastoma. At present, CCNU is also administered in patients with newly diagnosed gliomas in combination with temozo...

Descripción completa

Detalles Bibliográficos
Autores principales: Seliger, Corinna, Nürnberg, Christina, Wick, Wolfgang, Wick, Antje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155160/
https://www.ncbi.nlm.nih.gov/pubmed/35664555
http://dx.doi.org/10.1093/noajnl/vdac068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155160/
https://www.ncbi.nlm.nih.gov/pubmed/35664555
http://dx.doi.org/10.1093/noajnl/vdac068

Ejemplares similares